Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn’s disease

BACKGROUND: Mucosal healing (MH) is the key aim of the treat-to-target strategy for patients with Crohn’s disease (CD). The efficacy of infliximab (IFX) on MH in different ileocolonic segments is unclear. The aim of this study was to investigate endoscopic MH in different ileocolonic segments in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yaling, Zhang, Lei, Cao, Jingli, Wang, Haichao, Ye, Chen, Zhuoma, Deji, Yang, Pengyu, Wang, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758567/
https://www.ncbi.nlm.nih.gov/pubmed/33425009
http://dx.doi.org/10.1177/1756284820976923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758567/
https://www.ncbi.nlm.nih.gov/pubmed/33425009
http://dx.doi.org/10.1177/1756284820976923

Ejemplares similares